The Netherlands: Logtenberg and Hayden join Forbion as Venture Partners

Leading European life sciences venture capital firm, Forbion, has appointed two new Venture Partners: Dr Ton Logtenberg and Dr Michael Hayden. Logtenberg is a serial life sciences entrepreneur. He is the founder, former CEO and President of Merus, a clinical-stage oncology company; and founder and CEO of U-BiSys, a Dutch biotechnology company that merged with Introgene…

You must be a HMI Subscriber to view this content.

Subscribe Now »

Advertisement